RecruitingNCT06733766

Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer

Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer: A Multicenter Study


Sponsor

Chinese PLA General Hospital

Enrollment

300 participants

Start Date

Dec 9, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

To evaluate the long-term outcomes of ultrasound-guided thermal ablation for recurrent thyroid cancer


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at a minimally invasive procedure called thermal ablation — using heat delivered through a needle guided by ultrasound — to treat thyroid cancer that has come back after surgery. **You may be eligible if...** - You previously had thyroid surgery (thyroidectomy) for thyroid cancer - Your cancer has returned, and a biopsy confirmed it is malignant - There is no evidence the cancer has spread to other organs (no distant metastases) - You have been followed up for at least 12 months after surgery **You may NOT be eligible if...** - You have a blood clotting disorder - You have serious heart, breathing, liver, or kidney problems - The vocal cord on the side opposite your tumor is not working properly Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREultrasound-guided thermal ablation

microwave ablation, radiofrequency ablation, laser ablation


Locations(1)

Chinese PLA General Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06733766


Related Trials